Identifying metastatic renal cell carcinoma in thyroid fine-needle aspirates by molecular testing

in Endocrine-Related Cancer
Authors:
Tanner FreemanDepartment of Pathology, UPMC, Pittsburgh, Pennsylvania, USA

Search for other papers by Tanner Freeman in
Current site
Google Scholar
PubMed
Close
,
Charit TanejaDivision of Endocrinology and Metabolism, UPMC, Pittsburgh, Pennsylvania, USA

Search for other papers by Charit Taneja in
Current site
Google Scholar
PubMed
Close
https://orcid.org/0000-0002-7857-1255
,
N Paul OhoriDepartment of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

Search for other papers by N Paul Ohori in
Current site
Google Scholar
PubMed
Close
,
Abigail I WaldDepartment of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

Search for other papers by Abigail I Wald in
Current site
Google Scholar
PubMed
Close
,
John SkaugenDepartment of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

Search for other papers by John Skaugen in
Current site
Google Scholar
PubMed
Close
,
Linwah YipDepartment of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

Search for other papers by Linwah Yip in
Current site
Google Scholar
PubMed
Close
,
Seungwon KimDepartment of Otolaryngology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

Search for other papers by Seungwon Kim in
Current site
Google Scholar
PubMed
Close
,
Robert L FerrisDepartment of Otolaryngology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
UPMC Hillman Cancer Center, Department of Oncology, Pittsburgh, Pennsylvania, USA

Search for other papers by Robert L Ferris in
Current site
Google Scholar
PubMed
Close
,
Marina N NikiforovaDepartment of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

Search for other papers by Marina N Nikiforova in
Current site
Google Scholar
PubMed
Close
https://orcid.org/0000-0001-9976-9378
,
Somak RoyDepartment of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

Search for other papers by Somak Roy in
Current site
Google Scholar
PubMed
Close
, and
Yuri E NikiforovDepartment of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

Search for other papers by Yuri E Nikiforov in
Current site
Google Scholar
PubMed
Close
https://orcid.org/0000-0002-2239-1095

Correspondence should be addressed to Y E Nikiforov: nikiforovye@upmc.edu

(S Roy is now at Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, Ohio, USA)

Restricted access

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $1.00
USD  $1.00

USD  $1.00
USD  $1.00

Renal cell carcinoma (RCC) is the most common type of cancer found to metastasize to the thyroid gland. These tumors may represent a diagnostic challenge in cytology. However, most RCC tumors carry VHL alterations, which are rare in primary thyroid tumors. The aim of this study was to evaluate the utility of molecular testing in detecting metastatic RCC in thyroid fine-needle aspiration (FNA) samples. From November 2017 until March 2022, thyroid FNA samples with ThyroSeq v3 results showing both VHL alterations and low/absent expression of thyroid cell markers were analyzed. Eighteen samples from 15 patients met the inclusion criteria. On molecular analysis, deleterious VHL mutations were found in nine (50%) nodules, VHL copy number alteration (CNA) in two (11%), and both mutations and CNA in seven (39%). None of the cases showed mutations commonly found in thyroid tumors. The mean age of these patients was 68 (range, 49–89) years with a male to female ratio of 2:1. Eight (53%) patients had multiple thyroid nodules on ultrasound. On cytology, 14 (78%) nodules were diagnosed as Bethesda III, 2 (11%) as Bethesda IV, and 2 (11%) as Bethesda V. At the time of cytology review, the history of RCC, sometimes remote, was available for ten patients. Of the 14 patients with medical history or surgical follow-up available, all had history of RCC or renal mass or revealed metastatic RCC on thyroidectomy. This study demonstrates that molecular testing can reliably identify metastatic RCC in thyroid nodules with indeterminate cytology, which could improve patient management.

 

  • Collapse
  • Expand

Society for Endocrinology logo

  • Beutner U, Leowardi C, Bork U, Luthi C, Tarantino I, Pahernik S, Wente MN, Buchler MW, Schmied BM & Muller SA 2015 Survival after renal cell carcinoma metastasis to the thyroid: single center experience and systematic review of the literature. Thyroid 25 314324. (https://doi.org/10.1089/thy.2014.0498)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Calzolari F, Sartori PV, Talarico C, Parmeggiani D, Beretta E, Pezzullo L, Bovo G, Sperlongano P, Monacelli M & Lucchini R et al.2008 Surgical treatment of intrathyroid metastases: preliminary results of a multicentric study. Anticancer Research 28 28852888.

    • Search Google Scholar
    • Export Citation
  • Cancer Genome Atlas Research Network 2013 Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499 4349. (https://doi.org/10.1038/nature12222)

    • Search Google Scholar
    • Export Citation
  • Cancer Genome Atlas Research Network, Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ, Fei SS, Davis C, Wheeler DA, Murray BA & Schmidt L et al.2016 Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine 374 135145. (https://doi.org/10.1056/NEJMoa1505917)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Chung AY, Tran TB, Brumund KT, Weisman RA & Bouvet M 2012 Metastases to the thyroid: a review of the literature from the last decade. Thyroid 22 258268. (https://doi.org/10.1089/thy.2010.0154)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Cimino-Mathews A, Sharma R & Netto GJ 2011 Diagnostic use of PAX8, CAIX, TTF-1, and TGB in metastatic renal cell carcinoma of the thyroid. American Journal of Surgical Pathology 35 757761. (https://doi.org/10.1097/PAS.0b013e3182147fa8)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Feldman DE, Spiess C, Howard DE & Frydman J 2003 Tumorigenic mutations in VHL disrupt folding in vivo by interfering with chaperonin binding. Molecular Cell 12 12131224. (https://doi.org/10.1016/s1097-2765(0300423-4)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Gallou C, Joly D, Mejean A, Staroz F, Martin N, Tarlet G, Orfanelli MT, Bouvier R, Droz D & Chretien Y et al.1999 Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC. Human Mutation 13 464475. (https://doi.org/10.1002/(SICI)1098-1004(1999)13:6<464::AID-HUMU6>3.0.CO;2-A)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Hegerova L, Griebeler ML, Reynolds JP, Henry MR & Gharib H 2015 Metastasis to the thyroid gland: report of a large series from the Mayo Clinic. American Journal of Clinical Oncology 38 338342. (https://doi.org/10.1097/COC.0b013e31829d1d09)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Hoffman MA, Ohh M, Yang H, Klco JM, Ivan M & Kaelin WG 2001 Von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. Human Molecular Genetics 10 10191027. (https://doi.org/10.1093/hmg/10.10.1019)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Khaddour K, Marernych N, Ward WL, Liu J & Pappa T 2019 Characteristics of clear cell renal cell carcinoma metastases to the thyroid gland: a systematic review. World Journal of Clinical Cases 7 34743485. (https://doi.org/10.12998/wjcc.v7.i21.3474)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Kim E & Zschiedrich S 2018 Renal cell carcinoma in von Hippel-Lindau disease-from tumor genetics to novel therapeutic strategies. Frontiers in Pediatrics 6 16. (https://doi.org/10.3389/fped.2018.00016)

    • Search Google Scholar
    • Export Citation
  • Koch CA, Brouwers FM, Vortmeyer AO, Tannapfel A, Libutti SK, Zhuang Z, Pacak K, Neumann HPH & Paschke R 2006 Somatic VHL gene alterations in MEN2-associated medullary thyroid carcinoma. BioMed Central Cancer 17 131. (https://doi.org/10.1186/1471-2407-6-131)

    • Search Google Scholar
    • Export Citation
  • Lasseigne BN & Brooks JD 2018 The role of DNA methylation in renal cell carcinoma. Molecular Diagnosis and Therapy 22 431442. (https://doi.org/10.1007/s40291-018-0337-9)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Nakhjavani MK, Gharib H, Goellner JR & van Heerden JA 1997 Metastasis to the thyroid gland. A report of 43 cases. Cancer 79 574578. (https://doi.org/10.1002/(sici)1097-0142(19970201)79:3<574::aid-cncr21>3.0.co;2-#)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Nguyen M, He G & Lam AK 2022 Clinicopathological and molecular features of secondary cancer (metastasis) to the thyroid and advances in management. International Journal of Molecular Sciences 23 3242. (https://doi.org/10.3390/ijms23063242)

    • Search Google Scholar
    • Export Citation
  • Nikiforova MN, Mercurio S, Wald AI, de Moura MB, Callenberg K, Santana-Santos L, Gooding WE, Yip L, Ferris RL & Nikiforov YE 2018 Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules. Cancer 124 16821690. (https://doi.org/10.1002/cncr.31245)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Nixon IJ, Coca-Pelaz A, Kaleva AI, Triantafyllou A, Angelos P, Owen RP, Rinaldo A, Shaha AR, Silver CE & Ferlito A 2017 Metastasis to the thyroid gland: a critical review. Annals of Surgical Oncology 24 15331539. (https://doi.org/10.1245/s10434-016-5683-4)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Papi G, Fadda G, Corsello SM, Corrado S, Rossi ED, Radighieri E, Miraglia A, Carani C & Pontecorvi A 2007 Metastases to the thyroid gland: prevalence, clinicopathological aspects and prognosis: a 10-year experience. Clinical Endocrinology 66 565571. (https://doi.org/10.1111/j.1365-2265.2007.02773.x)

    • Search Google Scholar
    • Export Citation
  • Pusztaszeri M, Wang H, Cibas ES, Powers CN, Bongiovanni M, Ali S, Khurana KK, Michaels PJ & Faquin WC 2015 Fine-needle aspiration biopsy of secondary neoplasms of the thyroid gland: a multi-institutional study of 62 cases. Cancer Cytopathology 123 1929. (https://doi.org/10.1002/cncy.21494)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Rathmell WK, Hickey MM, Bezman NA, Chmielecki CA, Carraway NC & Simon MC 2004 In vitro and in vivo models analyzing von Hippel-Lindau disease-specific mutations. Cancer Research 64 85958603. (https://doi.org/10.1158/0008-5472.CAN-04-1430)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Russell JO, Yan K, Burkey B & Scharpf J 2016 Nonthyroid metastasis to the thyroid gland: case series and review with observations by primary pathology. Otolaryngology–Head and Neck Surgery 155 961968. (https://doi.org/10.1177/0194599816655783)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Signoretti S, Flaifel A, Chen YB & Reuter VE 2018 Renal cell carcinoma in the era of precision medicine: from molecular pathology to tissue-based biomarkers. Journal of Clinical Oncology 36 JCO2018792259. (https://doi.org/10.1200/JCO.2018.79.2259)

    • Search Google Scholar
    • Export Citation
  • Stergianos S, Juhlin CC, Zedenius J, Calissendorff J & Falhammar H 2021 Metastasis to the thyroid gland: characterization and survival of an institutional series spanning 28 years. European Journal of Surgical Oncology 47 13641369. (https://doi.org/10.1016/j.ejso.2021.02.018)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Takashima S, Takayama F, Wang JC, Saito A, Kawakami S, Kobayashi S & Sone S 2000 Radiologic assessment of metastases to the thyroid gland. Journal of Computer Assisted Tomography 24 539545. (https://doi.org/10.1097/00004728-200007000-00005)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Tong GX, Yu WM, Beaubier NT, Weeden EM, Hamele-Bena D, Mansukhani MM & O’Toole KM 2009 Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study. Modern Pathology 22 12181227. (https://doi.org/10.1038/modpathol.2009.88)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Willis RA 1931 Metastatic tumours in the thyreoid gland. American Journal of Pathology 7 187 .3208.3.

  • Wood K, Vini L & Harmer C 2004 Metastases to the thyroid gland: the Royal Marsden experience. European Journal of Surgical Oncology 30 583588. (https://doi.org/10.1016/j.ejso.2004.03.012)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Yoon JH, Kim EK, Kwak JY, Moon HJ & Kim GR 2014 Sonographic features and ultrasonography-guided fine-needle aspiration of metastases to the thyroid gland. Ultrasonography 33 4048. (https://doi.org/10.14366/usg.13014)

    • Search Google Scholar
    • Export Citation
  • Young AC, Craven RA, Cohen D, Taylor C, Booth C, Harnden P, Cairns DA, Astuti D, Gregory W & Maher ER et al.2009 Analysis of VHL gene alterations and their relationship to clinical parameters in sporadic conventional renal cell carcinoma. Clinical Cancer Research 15 75827592. (https://doi.org/10.1158/1078-0432.CCR-09-2131)

    • Crossref
    • Search Google Scholar
    • Export Citation